Print this article

Highlights on the ongoing APIs market situation

GIAN MARIO BACCALINI
President Aschimfarma

APIs (Active Pharmaceutical Ingredients) market is increasingly a global business integrated in the supply chain of pharmaceuticals, in which APIs represent the most important components in terms of clinical efficacy and value. Italy traditionally has a very strong and important APIs manufacturing base with a high level of technical competence, employing a range of skilled, highly qualified and experienced staff. Italian manufacturers forecast to close 2016 with the strengthening of the expressed growth trend during the last years, also thanks to the constant high level of export (a good 85% of their total turnover). The companies look at the future with optimism both some basic economic factors play a positive role, i.e. the price of oil and the exchange rate of Usd, and some specific